K. Yu

发表

Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects

Eunwoo Kim, A. Kim, Yujin Lee, 2021, Clinical and translational science.

A variant 2677A allele of the MDR1 gene affects fexofenadine disposition

D. Oh, Joo-Youn Cho, K. Yu, 2004, Clinical pharmacology and therapeutics.

Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markers.

Joo-Youn Cho, K. Yu, I. Jang, 2013, Journal of proteome research.

The HLA‐A*2402/Cw*0102 haplotype is associated with lamotrigine‐induced maculopapular eruption in the Korean population

K. Chu, D. Jeon, Soon-Tae Lee, 2015, Epilepsia.

HLA‐B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine‐induced maculopapular eruption

K. Chu, D. Jeon, Soon-Tae Lee, 2016, Epilepsia.

Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway

S. Cho, Joo-Youn Cho, K. Yu, 2015, Scientific Reports.

A physiologically‐based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+‐competitive acid blocker

K. Yu, Howard Lee, S. Jang, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities

K. Yu, I. Jang, J. Hwang, 2020, Alimentary pharmacology & therapeutics.

Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic

K. Yu, Jae-Yong Chung, J. Sunwoo, 2018, Drug design, development and therapy.

Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects

K. Yu, I. Jang, SeungHwan Lee, 2018, Drug design, development and therapy.

Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects

Joo-Youn Cho, K. Yu, I. Jang, 2012, Current medical research and opinion.

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects

Joo-Youn Cho, K. Yu, S. Yoon, 2016, Drug design, development and therapy.

Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation

K. Yu, H. Ryu, Jaeseong Oh, 2019, British journal of clinical pharmacology.

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians

K. Yu, Jieon Lee, SeungHwan Lee, 2018, Drug design, development and therapy.

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers

K. Yu, K. Lim, Yoonjung Choi, 2015, Drug design, development and therapy.

Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.

Joo-Youn Cho, K. Yu, I. Jang, 2010, Clinical therapeutics.

Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover

Joo-Youn Cho, K. Yu, I. Jang, 2011, Clinical therapeutics.

The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover study.

J. Kim, Joo-Youn Cho, K. Yu, 2009, Clinical therapeutics.

Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.

K. Yu, I. Jang, Sang-Goo Shin, 2009, Clinical therapeutics.

The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.

P. G. Choe, N. Kim, M. Oh, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of the UGT2B15 Genotype on the Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Intravenous Lorazepam in Healthy Volunteers

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2005, Clinical pharmacology and therapeutics.

Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013

C. Peck, K. Yu, Howard Lee, 2016, Drug design, development and therapy.

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Joo-Youn Cho, K. Yu, Jieon Lee, 2017, Drug design, development and therapy.

Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28‐0126 in healthy male subjects

Hyun-Jai Cho, Sang-Heon Cho, Soon Ha Kim, 2017, British Journal of Clinical Pharmacology.

Integrative Analysis of Renal Ischemia/Reperfusion Injury and Remote Ischemic Preconditioning in Mice.

C. Ahn, S. Min, Sanghyun Ahn, 2017, Journal of proteome research.

Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug

K. Oh, Y. Kim, D. Kim, 2014, BMC Nephrology.

Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects.

Sumin Yoon, A. Kim, Yujin Lee, 2020, Drug metabolism and pharmacokinetics.

Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon® and Eprex® following a single subcutaneous administration in healthy male volunteers

Sumin Yoon, Joo-Youn Cho, K. Yu, 2017, Drug design, development and therapy.

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects

K. Yu, I. Jang, SeungHwan Lee, 2020, Drug design, development and therapy.

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states

D. Oh, Kwang-Hyeon Liu, Joo-Youn Cho, 2004, Clinical pharmacology and therapeutics.

A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis

W. Park, K. Yu, I. Jang, 2019, Journal of clinical medicine.

Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese

K. Yu, I. Jang, Yoshiyasu Ohta, 2018, Drug design, development and therapy.

Pharmacokinetic and Pharmacodynamic Effects of Prasugrel in Healthy Korean Males

Kyung-Woo Park, K. Yu, R. Kelly, 2013, Journal of Cardiovascular Pharmacology.

Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2019, Scientific Reports.

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Sang-In Park, K. Yu, I. Jang, 2015, Drug design, development and therapy.

AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.

C. Ahn, K. Oh, H. Ryu, 2019, Biochemical and biophysical research communications.

A Randomized, Placebo Controlled, Double Blind, Parallel Group, Multiple Dosing, Dose Escalation Clinical Study to Evaluate Pharmacokinetics/Pharmacodynamics and Tolerability of Zofenopril in Healthy Korean Subjects

K. Yu, Jae-Yong Chung, I. Jang, 2013 .

Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin

Min Goo Lee, Joo-Youn Cho, K. Yu, 2013, Journal of clinical pharmacology.

The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid‐Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low‐Density Lipoprotein

Jayoun Kim, Y. Cho, Joo-Youn Cho, 2017, Basic & clinical pharmacology & toxicology.

Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects

K. Yu, J. Jeon, Min-Gul Kim, 2019, Drug design, development and therapy.

Seasonal Variation in Hemoglobin A1c in Korean Patients with Type 2 Diabetes Mellitus

Y. Cho, K. Yu, T. Oh, 2014, Journal of Korean medical science.

Therapeutic drug monitoring of vancomycin in a patient with Duchenne muscular dystrophy (DMD): A case report

K. Yu, Seonghae Yoon, Seung Hwan Lee, 2016 .

Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers.

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2010, Clinical therapeutics.

Population Pharmacokinetic Study of Prophylactic Fluconazole in Preterm Infants for Prevention of Invasive Candidiasis

K. Yu, S. Yoon, S. Shin, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects

K. Yu, I. Jang, K. Lim, 2014, American Journal of Cardiovascular Drugs.

Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2021, Drug design, development and therapy.

Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets

K. Yu, J. Hwang, SeungHwan Lee, 2020, Drug design, development and therapy.

Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.

K. Yu, J. Jeon, Min-Gul Kim, 2019, Clinical therapeutics.

Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials

Eunwoo Kim, K. Yu, I. Song, 2018, Pharmaceutical Research.

Pharmacokinetic Characteristics of Lafutidinein Healthy Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2007 .

Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects.

Joo-Youn Cho, K. Yu, I. Jang, 2010, Clinical therapeutics.

Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.

Ji Won Lee, N. Kim, June-Dong Park, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population

S. Ji, Joo-Youn Cho, K. Yu, 2019, Journal of clinical pharmacology.

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study

K. Yu, I. Jang, Sang-Min Cho, 2016, Drug design, development and therapy.

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers

K. Yu, K. Lim, Howard Lee, 2014, Drug design, development and therapy.

Pharmacokinetic Interaction of Fimasartan, a New Angiotensin II Receptor Antagonist, With Amlodipine in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2011, Journal of cardiovascular pharmacology.

The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarin.

J. Jung, Sang-Heon Cho, Hye‐Ryun Kang, 2011, The Tohoku journal of experimental medicine.

Favorable Outcome of Post-Transplantation Cyclophosphamide Haploidentical Peripheral Blood Stem Cell Transplantation with Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring in Pediatric Patients.

June-Dong Park, K. Yu, S. Song, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of cytochrome P450 2C19 genetic polymorphism and coadministration with ketoconazole on the platelet aggregation response to clopidogrel in Korean healthy subjects

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2009 .

Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects

Jongtae Lee, D. Yim, K. Yu, 2015, Drug design, development and therapy.

Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.

Joo-Youn Cho, K. Yu, I. Jang, 2014, British journal of clinical pharmacology.

Pharmacokinetic Profiles of Ceftazidime after Intravenous Administration in Patients Undergoing Automated Peritoneal Dialysis

C. Ahn, K. Oh, Y. Hwang, 2011, Antimicrobial Agents and Chemotherapy.

Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects

K. Yu, Jae-Yong Chung, I. Jang, 2018, The Journal of antimicrobial chemotherapy.

Safety , tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic , LCB 01-0371 , in healthy male subjects

K. Yu, Jae-Yong Chung, I. Jang, 2017 .

Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways

S. Ji, Joo-Youn Cho, K. Yu, 2019, Metabolomics.

Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension

K. Yu, S. Shin, Han-Suk Kim, 2022, Scientific Reports.

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects

K. Yu, I. Jang, SeungHwan Lee, 2020, Drug design, development and therapy.

Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2008, Clinical therapeutics.

Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects

K. Yu, I. Jang, SeungHwan Lee, 2020, Drug design, development and therapy.

Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects.

Joo-Youn Cho, K. Yu, I. Jang, 2008, British journal of clinical pharmacology.

Comparative Pharmacokinetics Between a Fixed‐Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects

Jinsook Kim, K. Yu, SeungHwan Lee, 2022, Clinical pharmacology in drug development.

HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model

C. Ahn, Miyeun Han, K. Oh, 2018, PloS one.

Pharmacokinetic and Pharmacodynamic Interaction Between Gemigliptin and Metformin in Healthy Subjects

Y. Cho, Joo-Youn Cho, K. Yu, 2014, Clinical Drug Investigation.

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers

K. Yu, Yong-Il Kim, Yu Kyong Kim, 2020, Translational and clinical pharmacology.

Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects

S. Chon, K. Yu, Dongseong Shin, 2019, Diabetes, metabolic syndrome and obesity : targets and therapy.

An Assessment of Pharmacokinetic Interaction between Lobeglitazone and Sitagliptin after Multiple Oral Administrations in Healthy Men.

K. Yu, Min-Gul Kim, S. Moon, 2020, Clinical therapeutics.

Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers.

Joo-Youn Cho, K. Yu, I. Jang, 2009, Basic & clinical pharmacology & toxicology.

Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study

K. Yu, I. Jang, SeungHwan Lee, 2021, Drug design, development and therapy.

DDDT_A_288986 651..658

K. Yu, I. Jang, SeungHwan Lee, 2021 .

A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects

Eunwoo Kim, K. Yu, I. Jang, 2019, Drug design, development and therapy.

Effects of Pregnane X Receptor (NR1I2) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2011, Drug Metabolism and Disposition.

Evaluation of Pharmacokinetics and Tolerability of Eplerenone after Multiple Oral Doses of 100 mg in Healthy Korean Volunteers

D. Oh, K. Yu, I. Jang, 2011 .

Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizers

Sang-In Park, A. Kim, S. Ji, 2020, The Pharmacogenomics Journal.

Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes

K. Yu, I. Jang, SeungHwan Lee, 2020, Translational and clinical pharmacology.

A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators.

Jihoon G. Yoon, Jihoon G Yoon, Joo-Youn Cho, 2020, Pharmacogenetics and genomics.

Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male Volunteers

Sang-In Park, K. Yu, I. Jang, 2017, Clinical Drug Investigation.

Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P‐glycoprotein Inhibitor, in Healthy Male Participants

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2013, Basic & clinical pharmacology & toxicology.

Liquid chromatography tandem mass spectrometry determination of bicalutamide in human plasma and application to a bioequivalence study

Joo-Youn Cho, K. Yu, Bora Kim, 2011 .

Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.

Joo-Youn Cho, K. Yu, I. Jang, 2011, Clinical therapeutics.

Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections

E. J. Kim, K. Yu, Jae-Yong Chung, 2019, Therapeutic drug monitoring.

A Detailed Analysis of Alcohol Pharmacokinetics in Healthy Korean Men

K. Yu, B. Song, K. Shin, 2015 .

A Detailed Analysis of Alcohol Pharmacokinetics in

K. Yu, B. Song, K. Shin, 2015 .

Pharmacokinetics and Tolerability Evaluation of Human Coagulation Recombinant Factor VIII (GreenGene^TM) in Hemophilia A Patients

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2011 .

The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2013, Current medical research and opinion.

Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin

Joo-Youn Cho, K. Yu, S. Yi, 2001, Clinical pharmacology and therapeutics.

The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.

Joo-Youn Cho, K. Yu, I. Jang, 2012, Clinical therapeutics.

Pharmacokinetic and Pharmacodynamic Evaluation of a Novel Proton Pump Inhibitor, YH1885, in Healthy Volunteers

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2004, Journal of clinical pharmacology.

Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.

K. Yu, Jae-Yong Chung, S. Yoon, 2021, Clinical pharmacology in drug development.

Pharmacokinetics and Tolerability Evaluation of Fudosteine after Oral Administration in Healthy Korean Volunteers

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2011 .

The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections

Ji Won Lee, K. Yu, H. Shin, 2015, Pediatric hematology and oncology.

Tolerability and pharmacokinetics of a new P-glycoprotein inhibitor, HM30181, in healthy Korean male volunteers: single- and multiple-dose randomized, placebo-controlled studies.

Joo-Youn Cho, K. Yu, I. Jang, 2012, Clinical therapeutics.

Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs

K. Yu, SeungHwan Lee, Ildae Song, 2022, Translational and clinical pharmacology.

Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects

K. Yu, I. Jang, J. Hwang, 2022, British journal of clinical pharmacology.

Pharmacokinetics and Pharmacodynamics of Oral Tolvaptan Administered in 15- to 60-mg Single Doses To Healthy Korean Men

Joo-Youn Cho, K. Yu, I. Jang, 2012, Journal of cardiovascular pharmacology.

Clinical Evaluation of Digital Therapeutics: Present and Future

K. Yu, SeungHwan Lee, Jaeseong Oh, 2022, Healthcare Informatics Research.

Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects

K. Yu, I. Jang, Donghwan Lee, 2021, Translational and clinical pharmacology.

A population PK–PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808

K. Yu, Howard Lee, S. Jang, 2022, CPT: pharmacometrics & systems pharmacology.

Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants

Joo-Youn Cho, K. Yu, E. Kim, 2017, British journal of clinical pharmacology.

Prediction of serum theophylline concentrations and CYP 1 A 2 activity by analyzing urinary metabolites in preterm infants ( Running head : CYP 1 A 2 activity and theophylline pharmacokinetics in preterm infants )

Joo-Youn Cho, K. Yu, H. S. Kim, 2016 .

Population Pharmacokinetics of Theophylline in Premature Korean Infants

Joo-Youn Cho, K. Yu, I. Jang, 2013, Therapeutic drug monitoring.

Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects.

Eunwoo Kim, Myungwon Jin, Soon Ha Kim, 2020, Clinical therapeutics.

Population Pharmacokinetics of Vancomycin in Korean Pediatric Patients

K. Yu, Jung-Ryul Kim, I. Jang, 2008 .

Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects

K. Yu, I. Jang, SeungHwan Lee, 2022, Frontiers in Pharmacology.

Pharmacokinetics of T-614 after Single Oral Administration in Healthy Korean Volunteers

K. Yu, Jung-Ryul Kim, I. Jang, 2013 .

Pharmacokinetic–Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2013, Basic & clinical pharmacology & toxicology.

Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects

Seung-Hwan Lee, K. Yu, J. Jeon, 2018, Translational and clinical pharmacology.

Comparison of Pharmacokinetics and Safety Between Coadministration of Cilostazol and Ginkgo Biloba Extract and Administration of a Fixed-Dose Combination

K. Yu, I. Jang, K. Lim, 2010 .

Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing

K. Yu, H. Shin, J. Choi, 2019, Bone Marrow Transplantation.

Usefulness of saliva for perampanel therapeutic drug monitoring

K. Chu, Soon-Tae Lee, Manho Kim, 2020, Epilepsia.

Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients

Ji Won Lee, K. Yu, S. Yoon, 2018, Bone Marrow Transplantation.

K. Yu, I. Jang, Sang Won Lee, 2022 .

Pharmacokinetics of a Fixed‐Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components

Sang-In Park, K. Yu, Jae-Yong Chung, 2021, Clinical pharmacology in drug development.

DDDT_A_303772 1735..1747

Joo-Youn Cho, K. Yu, I. Jang, 2021 .

The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects.

Sumin Yoon, A. Kim, Yujin Lee, 2020, Drug metabolism and pharmacokinetics.

Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers.

A. Kim, Joo-Youn Cho, K. Yu, 2019, Drug metabolism and pharmacokinetics.

Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females

A. Kim, Joo-Youn Cho, K. Yu, 2017, The AAPS Journal.

A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2017, Expert opinion on investigational drugs.

Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2013, BioDrugs.

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction

Jinho Yang, Yoon-Keun Kim, S. Ji, 2018, Scientific Reports.

Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy

K. Chu, Sang Kun Lee, Joo-Youn Cho, 2012, Epilepsia.

Relationship Between Absolute Neutrophil Count Profiles and Pharmacokinetics of DA-3031, a Pegylated Granulocyte Colony-Stimulating Factor (Pegylated-G-CSF): A Dose Block-Randomized, Double-Blind, Dose-Escalation Study in Healthy Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2013, Clinical Drug Investigation.

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects.

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2008, British journal of clinical pharmacology.

Quantification of Ticlopidine in Human Plasma Using Protein Precipitation and Liquid Chromatography Coupled with Tandem Mass Spectrometry

Joo-Youn Cho, K. Yu, I. Jang, 2011 .

An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects

K. Yu, I. Jang, K. Lim, 2014, Investigational new drugs.

Tolerability and Pharmacokinetics Following a Single Dose of Vardenafil in Healthy Korean Volunteers

K. Yu, Hyeong-Seok Lim, I. Jang, 2012 .

Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state

Joo-Youn Cho, K. Yu, I. Jang, 2014, Drug design, development and therapy.

Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study.

Joo-Youn Cho, K. Yu, I. Jang, 2012, Clinical therapeutics.

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study

K. Yu, I. Jang, SeungHwan Lee, 2022, Clinical and translational science.

Pharmacokinetics, Pharmacodynamics and Safety of JES9501 after Single and Multiple Oral Administration in Healthy Subjects

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2013 .

Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers

Jong Sun Park, Sang-In Park, K. Yu, 2015, Antimicrobial Agents and Chemotherapy.

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole

J. Kwon, D. Kang, Jung-Seok Choi, 2008, European Neuropsychopharmacology.

Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment

Sumin Yoon, K. Yu, Jae-Yong Chung, 2019, Translational and clinical pharmacology.

Efficacy and safety of a new ranibizumab biosimilar CKD-701 using a pro re nata treatment regimen in neovascular age-related macular degeneration: A phase 3 randomized clinical trial

K. Yu, Jaeryung Oh, K. Bae, 2022, PloS one.

Removal of Amikacin in Patients Undergoing Continuous Venovenous Hemodiafiltration

K. Oh, Y. Kim, K. Yu, 2006 .

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.

Ah Ram Lee, F. Zoulim, Jung-Hwan Yoon, 2019, Journal of hepatology.

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy

S. I. Lee, K. Chu, Joo-Youn Cho, 2009, Epilepsy Research.

Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019

Eunwoo Kim, K. Yu, Seonghae Yoon, 2021, Frontiers in Pharmacology.

Validated LC-MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies.

Joo-Youn Cho, K. Yu, I. Jang, 2015, Journal of chromatographic science.

Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry

Ji Won Lee, K. Yu, S. Song, 2013, Annals of laboratory medicine.

The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension

Sang-In Park, Y. Koh, P. G. Choe, 2018, Antimicrobial Agents and Chemotherapy.

Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies

Y. Koh, P. G. Choe, N. Kim, 2017, Infection & chemotherapy.

Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy.

Sang-In Park, Y. Koh, P. G. Choe, 2016, International journal of antimicrobial agents.

Assessment of induced CYP3A activity in pregnant women using 4β-hydroxycholesterol: Cholesterol ratio as an appropriate metabolic marker.

S. M. Lee, S. Kim, Joong-Shin Park, 2018, Drug metabolism and pharmacokinetics.

Pharmacokinetic and pharmacodynamic properties of the calcimimetic agent cinacalcet (KRN1493) in healthy male Korean subjects: a randomized, open-label, single ascending-dose, parallel-group study.

K. Yu, I. Jang, K. Lim, 2012, Clinical therapeutics.

Voriconazole-associated severe hyponatremia.

N. Kim, M. Oh, W. Park, 2012, Medical mycology.

Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects

K. Yu, I. Jang, J. Hyon, 2022, Pharmaceuticals.

Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjects.

Joo-Youn Cho, K. Yu, I. Jang, 2010, British journal of clinical pharmacology.

Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine.

Joo-Youn Cho, K. Yu, Hyeong-Seok Lim, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Comparison of the Pharmacokinetics Between Udenafil 100 mg tablets and 200 mg tablets in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2008 .

Single-dose Pharmacokinetics of Garenoxacin in Healthy Korean Volunteers

K. Yu, I. Jang, Tae-Eun Kim, 2010 .

High-Performance Liquid Chromatographic Assay of Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in Human Plasma using a Solid-Phase Extraction Technique

Kwang-Hyeon Liu, K. Yu, Jae-Gook Shin, 2004 .

Investigating the Different Mechanisms of Genotoxic and Non-Genotoxic Carcinogens by a Gene Set Analysis

Johan Lim, Sung Won Kwon, S. Lee, 2014, PloS one.

Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2010, Clinical therapeutics.

Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

Ji Won Lee, June-Dong Park, K. Yu, 2015, Clinical Drug Investigation.

Voriconazole Therapeutic Drug Monitoring is Necessary for Children with Invasive Fungal Infection

Hyun Ju Lee, Ji Won Lee, K. Yu, 2014 .

Risk factors for suboptimal drug concentration of posaconazole oral suspension in patients with hematologic malignancy.

Y. Koh, P. G. Choe, N. Kim, 2017, Journal de mycologie medicale.

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration

K. Yu, Anhye Kim, Jaeseong Oh, 2023, Pharmaceuticals.

Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.

J. Kwon, D. Kang, Y. Kim, 2008, British journal of clinical pharmacology.

Reduced Valproic Acid Serum Concentrations Due to Drug Interactions With Carbapenem Antibiotics: Overview of 6 Cases

Joo-Youn Cho, K. Yu, I. Jang, 2012, Therapeutic drug monitoring.

Cytoplasmic zinc promotes IL-1β production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis

J. Park, K. Yu, S. Yoo, 2022, Science Signaling.

HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION

Joo-Youn Cho, K. Yu, Hyeong-Seok Lim, 2004, Drug Metabolism and Disposition.

Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2014, Drug design, development and therapy.

Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer.

S. Shreeve, Mikyung Kim, K. Yu, 2022, Lung cancer.

Genetic Polymorphisms of the Carboxylesterase 1 (CES1) Gene in a Korean Population

Eun-Young Kim, Joo-Youn Cho, K. Yu, 2014 .

Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment

Youngjo Lee, Y. Sugiyama, Joo-Youn Cho, 2014, Pharmacogenetics and genomics.

A Placebo-Controlled, Single and Multiple Dose Study to Investigate the Appropriate Parameters for Evaluation of Pharmacodynamic Equivalence of Voglibose in Healthy Korean Volunteers

Sang-Heon Cho, K. Yu, I. Jang, 2013 .

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers

D. Oh, Joo-Youn Cho, K. Yu, 2005, Clinical pharmacology and therapeutics.

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib

K. Yu, Jaeseong Oh, Sang Yeob Park, 2021, Pharmaceutics.

Pharmacokinetic comparison of two levofloxacin 100-mg tablet formulations and determination of time point appropriately reflecting its area under the curve

Seung-Hwan Lee, S. Yim, K. Yu, 2016 .

Trough Concentration Over 12.1 mg/L is a Major Risk Factor of Vancomycin-Related Nephrotoxicity in Patients With Therapeutic Drug Monitoring

Ju Han Kim, Sang-Heon Cho, Hye‐Ryun Kang, 2014, Therapeutic drug monitoring.

Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole

K. Yu, I. Jang, Bongtae Kim, 2022, British journal of clinical pharmacology.

Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects

S. Ji, K. Yu, I. Jang, 2020, Alimentary pharmacology & therapeutics.

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication

K. Yu, Yu Kyong Kim, Hyewon Chung, 2021, British journal of clinical pharmacology.

Comparative Pharmacokinetics/Pharmacodynamics of Clopidogrel Besylate and Clopidogrel Bisulfate in Healthy Korean Subjects

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2012, Clinical Drug Investigation.

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects

Beesan Tan, Lee E Kirsch, H. Naik, 2009, Malaria Journal.

Simultaneous LC–MS–MS Determination of HM30181A, [2-(2-{4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]amide, as a new P-Glycoprotein Inhibitor and Its Two Metabolites, M1 and M2, in Human Plasma: Application to a Pharmacokinetic Study

Y. Choi, Joo-Youn Cho, K. Yu, 2011 .

Comparison of R(+)-α-lipoic acid exposure after R(+)-α-lipoic acid 200 mg and 300 mg and thioctic acid 600 mg in healthy Korean male subjects

K. Yu, I. Jang, S. Yoon, 2016 .

Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease

Ji Won Lee, June-Dong Park, K. Yu, 2016, Korean journal of pediatrics.

Pharmacokinetics of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Ji Won Lee, K. Yu, I. Jang, 2014 .

Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids.

Eunwoo Kim, Yujin Lee, Joo-Youn Cho, 2021, Diabetes research and clinical practice.

Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.

Ji Won Lee, N. Kim, K. Yu, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetic comparison and bioequivalence evaluation of two 10-mg baclofen formulations in healthy male subjects .

S. Yim, Sumin Yoon, K. Yu, 2017, International journal of clinical pharmacology and therapeutics.

Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study

Jun Soo Kwon, Euitae Kim, Young Youn Kim, 2006, Human psychopharmacology.

Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole

K. Yu, I. Jang, SeungHwan Lee, 2021, Drug design, development and therapy.

DDDT_A_341271 5099..5108

K. Yu, I. Jang, SeungHwan Lee, 2021 .

Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects

Joo-Youn Cho, K. Yu, I. Jang, 2016, Drug design, development and therapy.

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2009, British journal of clinical pharmacology.

Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia

J. Lim, Soo-Youn Lee, K. Yu, 2018, Therapeutic drug monitoring.

Effect of Erythrocyte Thiopurine Methyltransferase (TPMT) Activity on Azathioprine Immunosuppression Therapy in Renal Transplant Recipients

C. Ahn, J. Ha, Joo-Youn Cho, 2000 .

Identification of ω‐ or (ω‐1)‐Hydroxylated Medium‐Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity

Joo-Youn Cho, K. Yu, I. Jang, 2018, Clinical pharmacology and therapeutics.

Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese

K. Yu, I. Jang, SeungHwan Lee, 2021, Clinical and translational science.

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers

M. Seong, Joo-Youn Cho, K. Yu, 2017, Antimicrobial Agents and Chemotherapy.

Clinical usefulness of serum cystatin C and the pertinent estimation of glomerular filtration rate based on cystatin C

Y. Lim, Y. Kim, Ho Kim, 2010, Nephrology.

A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With Hypertension

B. Oh, K. Yu, I. Jang, 2013, Clinical pharmacology in drug development.

Validation of the Korean coefficient for the modification of diet in renal disease study equation

Y. Kim, K. Yu, S. Kim, 2016, The Korean journal of internal medicine.

Ethnic Coefficients for Glomerular Filtration Rate Estimation by the Modification of Diet in Renal Disease Study Equations in the Korean Population

Y. Lim, Kai Song, Y. Kim, 2010, Journal of Korean medical science.

Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II

Hyeong-Seok Lim, Kyun-Seop Bae, Sang-Goo Shin, 2006, European Journal of Clinical Pharmacology.

Pharmacodynamics, Pharmacokinetics, and Tolerability of Intravenous or Subcutaneous GC1113, a Novel Erythropoiesis-Stimulating Agent

Jongtae Lee, Joo-Youn Cho, K. Yu, 2014, Clinical Drug Investigation.

Simple and sensitive determination of the new antitumor drug CKD-602 in human plasma by liquid chromatography.

Joo-Youn Cho, K. Yu, S. Yi, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The use of healthy volunteers instead of patients to inform drug dosing studies: a [11C]raclopride PET study

F. Turkheimer, S. Kapur, J. Kwon, 2011, Psychopharmacology.

Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.

K. Yu, I. Jang, K. Lim, 2012, Clinical therapeutics.

Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients

Ji Won Lee, Joo-Youn Cho, K. Yu, 2017, Scientific Reports.

Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers

J. Kwon, H. Jo, Jong-Min Lee, 2008, Pharmacogenetics and genomics.

Impact of Vancomycin‐Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin

A. Kim, S. Ji, Joo-Youn Cho, 2020, Clinical and translational science.

Pharmacokinetics and Tolerability of Naftopidil after a Single Oral Administration in Healthy Korean Volunteers

K. Yu, I. Jang, SeungHwan Lee, 2010 .

Assessment of the Drug–Drug Interactions Between Fimasartan and Hydrochlorothiazide in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2012, Journal of cardiovascular pharmacology.

Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2013, BioDrugs.

A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2016, International clinical psychopharmacology.

Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects

K. Yu, I. Jang, Howard Lee, 2015, Drug design, development and therapy.

Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach

Joo-Youn Cho, K. Yu, I. Jang, 2016, AAPS Journal.

Influence of Simvastatin on Pharmacokinetics/Pharmacodynamics of Aspirin after Oral Co-administration in Healthy Volunteers

D. Yim, K. Yu, I. Jang, 2011 .

Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy

K. Chu, Soon-Tae Lee, K. Jung, 2022, Epilepsia.

The necessary conduct: Exploratory multiregional clinical trials in East Asia

K. Yu, I. Jang, Inseung Jeon, 2021, Clinical and translational science.

Comparative Pharmacokinetics of HD203, a Biosimilar of Etanercept, with Marketed Etanercept (Enbrel ®)

Joo-Youn Cho, K. Yu, I. Jang, 2012, BioDrugs.

Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole

K. Yu, SeungHwan Lee, Ji-Yong Kwon, 2023, Drug design, development and therapy.

A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects

K. Yu, SeungHwan Lee, Yu Kyong Kim, 2017, Drug design, development and therapy.

Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects

Eunwoo Kim, K. Yu, SeungHwan Lee, 2021, Translational and clinical pharmacology.

A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy

K. Yu, Jaeseong Oh, J. Jeon, 2021, Translational and clinical pharmacology.

Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers.

K. Yu, I. Jang, Tae-Eun Kim, 2010, Clinical therapeutics.

Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects

D. Furst, K. Yu, Hyeong-Seok Lim, 2021, Clinical and translational science.

Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies.

K. Yu, Jung-Ryul Kim, I. Jang, 2010, Clinical therapeutics.

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study

Jongtae Lee, Y. Kim, K. Yu, 2014, Drug design, development and therapy.

Effect of age on the pharmacokinetics of fimasartan (BR-A-657)

Joo-Youn Cho, K. Yu, J. Seo, 2011, Expert opinion on drug metabolism & toxicology.

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis

T. Park, E. Cho, Joo-Youn Cho, 2019, Cancers.

Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium–glucose cotransporter 2 inhibitor and metformin in healthy subjects

K. Yu, I. Jang, J. Hwang, 2022, British journal of clinical pharmacology.

Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2022, Clinical Therapeutics.

Optimization and Validation of a Fluorogenic Dipeptidyl Peptidase 4 enzymatic assay in Human Plasma.

Hyunyee Yoon, M. Song, K. Yu, 2020, Analytical biochemistry.

Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers

Sang-In Park, K. Yu, Ju-Young Jung, 2019, Drug design, development and therapy.

URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers.

Sang-In Park, K. Yu, Hyun A Lee, 2019, Rheumatology.

Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK‐30, and From Red Ginseng Extract in Healthy Korean Subjects

K. Yu, I. Jang, SeungHwan Lee, 2021, Clinical pharmacology in drug development.

Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects

S. Ji, K. Yu, SeungHwan Lee, 2023, Alimentary pharmacology & therapeutics.

Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers.

K. Yu, I. Jang, Tae-Eun Kim, 2011, Clinical therapeutics.

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Sang-Heon Cho, Joo-Youn Cho, K. Yu, 2014, Drug design, development and therapy.

Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation

Sumin Yoon, K. Yu, O. Hatley, 2019, Biopharmaceutics & drug disposition.

Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.

K. Yu, I. Jang, Howard Lee, 2017, Clinical therapeutics.

Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Potassium Channel Opener, SKP‐450, in Healthy Volunteers

Joo-Youn Cho, K. Yu, S. Yi, 2000, Journal of clinical pharmacology.

The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans

Joo-Youn Cho, K. Yu, I. Jang, 2017, PloS one.

Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.

D. Yim, Joo-Youn Cho, K. Yu, 2002, British journal of clinical pharmacology.

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects.

K. Yu, I. Jang, Jaeseong Oh, 2023, Clinical and translational science.

1 EVALUATION OF COMPARATIVE PHARMACOKINETICS AND BIOEQUIVALENCE OF A NEW 1 ACECLOFENAC FORMULATION 2 3

S. Yim, K. Yu, Jaeseong Oh, 2008 .

Pharmacokinetic and Pharmacodynamic Characteristics of Tripegfilgrastim, a Pegylated G‐CSF, in Pediatric Patients with Solid Tumors

Joo-Youn Cho, K. Yu, I. Jang, 2021, Clinical pharmacology and therapeutics.

Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2011, Clinical therapeutics.

In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy.

Y. Kim, Joo-Youn Cho, K. Yu, 2011, American journal of physiology. Renal physiology.

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Joo-Youn Cho, K. Yu, S. Schneider, 2014, Drug design, development and therapy.

Cytoplasmic zinc regulates IL-1β production by monocytes/macrophages via mTORC1-induced glycolysis in rheumatoid arthritis (RA)

J. Park, K. Yu, Won-Woo Lee, 2021, bioRxiv.

Effect of UGT2B7 Genotype on Pharmacokinetics of Valproate in Human Healthy Subjects

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2004 .

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.

K. Yu, I. Jang, S. Yoon, 2009, Clinical therapeutics.

The Effect of the Newly Developed Angiotensin Receptor II Antagonist Fimasartan on the Pharmacokinetics of Atorvastatin in Relation to OATP1B1 in Healthy Male Volunteers

Min Goo Lee, Joo-Youn Cho, K. Yu, 2011, Journal of cardiovascular pharmacology.

Effects of perampanel on cognition and quantitative electroencephalography in patients with epilepsy

Kwang Su Cha, K. Chu, J. Sunwoo, 2020, Epilepsy & Behavior.

Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.

Joong-Shin Park, K. Yu, I. Jang, 2013, Contraception.

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects

Joo-Youn Cho, K. Yu, I. Jang, 2017, Drug design, development and therapy.

Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects

Eunwoo Kim, Joo-Youn Cho, K. Yu, 2018, European Journal of Clinical Pharmacology.

Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment

Sumin Yoon, A. Kim, Yujin Lee, 2018, Journal of Korean medical science.

Predictive performance of gentamicin dosing nomograms

K. Yu, K. Lim, Howard Lee, 2014, Drug Design, Development and Therapy.

Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers.

K. Yu, I. Jang, K. Lim, 2009, Clinical therapeutics.

Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study.

Sang-Heon Cho, K. Yu, I. Jang, 2014, Clinical therapeutics.

A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring.

K. Yu, H. Shin, J. Choi, 2017, Therapeutic drug monitoring.

An efficient and effective ensemble of support vector machines for anti-diabetic drug failure prediction

Sungzoon Cho, Pilsung Kang, Seokho Kang, 2015, Expert Syst. Appl..

Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ‐149 Injections in Healthy Volunteers: A First‐in‐Class, First‐in‐Human Study

K. Yu, Anhye Kim, SeungHwan Lee, 2018, Journal of clinical pharmacology.

A positron emission tomography microdosing study with sertraline in healthy volunteers.

Jae Sung Lee, Yun-Sang Lee, Kwang-Hee Shin, 2012, International journal of clinical pharmacology and therapeutics.

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers

Joo-Youn Cho, K. Yu, Sang-Hyuk Lee, 2017, Drug design, development and therapy.

Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy

K. Chu, Soon-Tae Lee, K. Jung, 2017, Epilepsy Research.

Pharmacokinetic characteristics of bepotastine besilate in healthy subjects

K. Yu, Hyeong-Seok Lim, I. Jang, 2007 .

An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record database

Sang-In Park, K. Yu, I. Jang, 2016, Expert opinion on drug safety.

Trends of clinical trials from 2017 to 2019 in Korea: an integrated analysis based on the Ministry of Food and Drug Safety (MFDS) and the Clinical Research Information Service (CRIS) registries

Hyungsub Kim, K. Yu, Hyeong-Seok Lim, 2021, Translational and clinical pharmacology.

An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans

S. Dueker, H. Lee, K. Yu, 2020, Clinical and translational science.

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials

Joo-Youn Cho, K. Yu, I. Jang, 2017, Drug design, development and therapy.

Pharmacokinetics and tolerability of MB 12066 , a beta-lapachone derivative targeting naD ( P ) h : quinone oxidoreductase 1 : two independent , double-blind , placebo-controlled , combined single and multiple ascending dose first-inhuman clinical trials

Joo-Youn Cho, K. Yu, I. Jang, 2017 .

An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.

K. Yu, Jung-Ryul Kim, I. Jang, 2009, Clinical therapeutics.

Pharmacokinetic properties and tolerability of rotigotine transdermal patch after repeated-dose application in healthy korean volunteers.

K. Yu, Jung-Ryul Kim, I. Jang, 2015, Clinical therapeutics.

Apple juice greatly reduces systemic exposure to atenolol.

K. Ohashi, Joo-Youn Cho, K. Yu, 2013, British journal of clinical pharmacology.

Calculating Occupancy when One does not have Baseline: A Comparison of Different Options

S. Kapur, J. Kwon, O. Howes, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females

A. Kim, Joo-Youn Cho, K. Yu, 2017, The AAPS Journal.

A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles

Joo-Youn Cho, K. Yu, I. Jang, 2015, Drug design, development and therapy.

Evaluation of factors associated with drug-induced liver injury using electronic medical records

K. Yu, H. Chung, Jieon Lee, 2016 .

Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients

Ji Won Lee, Joo-Youn Cho, K. Yu, 2017, Scientific Reports.

Effects of Proton Pump Inhibitors on Metformin Pharmacokinetics and Pharmacodynamics

Joo-Youn Cho, K. Yu, I. Jang, 2014, Drug Metabolism and Disposition.

Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction

Jinho Yang, Yoon-Keun Kim, S. Ji, 2018, Scientific Reports.

Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform

Joo-Youn Cho, K. Yu, I. Jang, 2021, Translational and clinical pharmacology.

Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects

Joo-Youn Cho, K. Yu, I. Jang, 2019, Scientific Reports.

Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once‐daily intravenous busulfan dosing nomogram

Ji Won Lee, K. Yu, S. Song, 2017, American journal of hematology.

Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteers.

Joo-Youn Cho, K. Yu, I. Jang, 2012, International journal of clinical pharmacology and therapeutics.

Comparison of the Pharmacokinetics of a Fixed‐Dose Combination of Rosuvastatin/Metformin Sustained‐Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects

Eunwoo Kim, H. Suh, K. Yu, 2020, Clinical pharmacology in drug development.

Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials

Eunwoo Kim, K. Yu, I. Song, 2018, Pharmaceutical Research.

Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations

Su-jin Rhee, Jae-Yong Chung, K. Yu, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

No associations between 5-HTT, 5-HT2A gene polymorphisms and obsessive-compulsive disorder in a Korean population

J. Kwon, S. Yoo, Joo-Youn Cho, 2006 .

Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.

W. Park, Joo-Youn Cho, K. Yu, 2011, Vaccine.

Identification of Gene Expression Changes in Whole Blood Indicative of Exposure to Chemicals with Different Target Organ Toxicity

K. Yu, N. DelRaso, Victor Chan, 2006 .

Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies

Sang-In Park, Y. Koh, P. G. Choe, 2017, Therapeutic drug monitoring.

CPT: Pharmacometrics & Systems Pharmacology

Ghent, M. Jamei, D. Ashcroft, 2013, CPT: pharmacometrics & systems pharmacology.

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2012, Journal of clinical pharmacology.

Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram

W. Park, K. Yu, S. Song, 2018, Basic & clinical pharmacology & toxicology.

A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study

Joo-Youn Cho, K. Yu, S. Yoon, 2018, PloS one.

Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase‐4 inhibitor, evogliptin (DA‐1229)

A. Kim, Joo-Youn Cho, K. Yu, 2017, Diabetes, obesity & metabolism.

Ethnic Coefficients for Glomerular Filtration Rate Estimation by the Modification of Diet in Renal Disease Study Equations in the Korean Population

Y. Lim, Kai Song, K. Yu, 2010, Journal of Korean medical science.

Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2009, Clinical therapeutics.

Safety, Tolerability, and Pharmacokinetics of a Novel Macrocyclic Gadolinium-Based Contrast Agent, HNP-2006, in Healthy Subjects.

S. Choi, K. Yu, Heejeong Lee, 2023, Investigative radiology.

LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2017, BioDrugs.

Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers

K. Yu, I. Jang, Jaeseong Oh, 2022, Clinical and translational science.

The Effects of Moxifloxacin on QTc Interval in Healthy Korean Male Subjects

Jongtae Lee, D. Yim, Joo-Youn Cho, 2014, Drugs in R&D.

Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel DPP-IV inhibitor , evogliptin ( DA-1229 )

Joo-Youn Cho, K. Yu, I. Jang, 2016 .

Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg .

Sang-In Park, Sumin Yoon, Joo-Youn Cho, 2017, International journal of clinical pharmacology and therapeutics.

Comparison of Pharmacokinetics and Safety of Ranolazine PR between Koreans and Caucasians.

Joo-Youn Cho, K. Yu, I. Jang, 2021, Clinical Therapeutics.

Tolerability and Pharmacokinetics of Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, After a Single Oral Administration in Healthy Female Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2014, Clinical Drug Investigation.

Reliable prediction of anti-diabetic drug failure using a reject option

Sungzoon Cho, Seokho Kang, Su-jin Rhee, 2017, Pattern Analysis and Applications.

Analysis of the distribution of trial sites in South Korea using social network analysis

K. Yu, Ildae Song, K. Y. Huh, 2023, Translational and clinical pharmacology.

Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects

Joo-Youn Cho, K. Yu, Jaeseong Oh, 2023, Drug design, development and therapy.

Effect of Oseltamivir on Bleeding Risk Associated with Warfarin Therapy

J. Jung, Sang-Heon Cho, Hye‐Ryun Kang, 2012, Clinical Drug Investigation.

Factors in ﬂ uencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

S. Chon, K. Yu, Y. Eom, 2019 .

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

Joo-Youn Cho, K. Yu, I. Jang, 2018, Genomics & informatics.

Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study

J. Smolen, K. Yu, G. Burmester, 2023, Expert opinion on investigational drugs.

HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION

Joo-Youn Cho, K. Yu, Hyeong-Seok Lim, 2004, Drug Metabolism and Disposition.

Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans

S. Yoon, A. Kim, Joo-Youn Cho, 2016, Diabetes, obesity & metabolism.

Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects

K. Yu, J. Hyon, J. You, 2022, Clinical and translational science.

Assessment of the Analgesic Effect of Remifentanil using Three Pain Models in Healthy Korean Volunteers: A Randomized, Controlled Study

K. Yu, I. Jang, Tae-Eun Kim, 2012, Basic & clinical pharmacology & toxicology.

Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects

K. Yu, K. Jang, J. Chung, 2016, Journal of clinical pharmacology.

Pharmacokinetics and effect on the corrected QT interval of single-dose escitalopram in healthy elderly compared with younger adults

Sang-In Park, Joo-Youn Cho, K. Yu, 2017, International clinical psychopharmacology.

Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers

K. Yu, I. Jang, SeungHwan Lee, 2018, Drug design, development and therapy.

Ji Won Lee, N. Kim, June-Dong Park, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Joo-Youn Cho, K. Yu, I. Jang, 2010, Clinical therapeutics.

The HLA‐A*2402/Cw*0102 haplotype is associated with lamotrigine‐induced maculopapular eruption in the Korean population

K. Chu, Soon-Tae Lee, J. Sunwoo, 2015, Epilepsia.

Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects

Joo-Youn Cho, K. Yu, I. Jang, 2021, Drug design, development and therapy.

K. Yu, Jung-Ryul Kim, I. Jang, 2010, Clinical therapeutics.

Pharmacokinetic Proﬁles of Ceftazidime after Intravenous Administration in Patients Undergoing Automated Peritoneal Dialysis

C. Ahn, K. Oh, Y. Hwang, 2011 .

Assessment of pharmacokinetic proportionality of levofloxacin and cyclosporine over a 100-fold dose range in healthy human volunteers

K. Yu, J. Seo, Y. Yoon, 2012, Expert opinion on drug metabolism & toxicology.

Prediction of gastric pH‐mediated drug exposure using physiologically‐based pharmacokinetic modeling: A case study of itraconazole

K. Yu, SeungHwan Lee, Eunsol Yang, 2023, CPT: pharmacometrics & systems pharmacology.

comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and ViMOVO ® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers

K. Yu, K. Lim, Yoonjung Choi, 2015 .

novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state

K. Yu, I. Jang, K. Lim, 2014 .

novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state

K. Yu, I. Jang, K. Lim, 2014 .